BioCentury | May 16, 2017
Distillery Techniques

Disease models; drug platforms

TECHNOLOGY: Animal models; cell therapy An in vitro method for generating hPSCs with extended developmental potency could be used to generate cell-based regenerative therapies and chimeric animal models of disease. The method involved treating hPSCs...
BioCentury | Mar 24, 2014
Company News

Veracyte management update

...Julie Brooks as EVP, general counsel and secretary, formerly EVP, general counsel and secretary at Conceptus Inc....
BioCentury | Jun 17, 2013
Company News

Conceptus, Bayer deal

...Bayer completed its acquisition of Conceptus for $31 per share, or about $1.1 billion (see BioCentury...
...for $31 per share, or about $1.1 billion (see BioCentury, May 6 & May 13). Conceptus Inc....
BioCentury | May 13, 2013
Company News

Conceptus, Bayer deal

...began its tender offer to acquire Conceptus for $31 per share, which Bayer says values Conceptus...
...about $1.1 billion. The offer expires at midnight on June 5 (see BioCentury, May 6). Conceptus Inc....
BioCentury | May 6, 2013
Company News

Conceptus, Bayer deal

...Bayer says values Conceptus at about $1.1 billion. The price is a 20% premium to Conceptus'...
...of $25.90 on April 26, the last trading day prior to the announcement. Bayer gains Conceptus'...
...flexible inserts into the fallopian tubes. In 2012, Conceptus reported $141 million in net sales. Conceptus Inc....
BioCentury | Oct 12, 2009
Company News

American Medical Systems Holdings, Conceptus deal

...Women's health company Conceptus acquired from American Medical full rights to the Essure birth control system...
...purchase of all patents and IP associated with Ovion Inc. for $23.6 million in cash. Conceptus...
...tubes. American Medical acquired Ovion in 2005. American Medical Systems Holdings Inc. (NASDAQ:AMMD), Minnetonka, Minn. Conceptus Inc....
BioCentury | Feb 16, 2004
Company News

Caliper board of directors update

...Sciences Inc. (CALP), Hopkinton, Mass. Business: Microarrays Appointed: Kathryn Tunstall, former president and CEO of Conceptus Inc....
BioCentury | Feb 9, 2004
Company News

Caliper board of directors update

...Sciences Inc. (CALP), Hopkinton, Mass. Business: Microfluidics Appointed: Kathryn Tunstall, former president and CEO of Conceptus Inc....
BioCentury | Mar 8, 1999
Strategy

Spinner on the block

...from the sale of Target shares in the open market. Target spawned its own company, Conceptus Inc....
BioCentury | Jan 18, 1993
Strategy

What's driving spate of spin-offs

...one program," he said. Another CGEN offspring, Target Therapeutics Inc., just spawned its own company, Conceptus...
Items per page:
1 - 10 of 10
BioCentury | May 16, 2017
Distillery Techniques

Disease models; drug platforms

TECHNOLOGY: Animal models; cell therapy An in vitro method for generating hPSCs with extended developmental potency could be used to generate cell-based regenerative therapies and chimeric animal models of disease. The method involved treating hPSCs...
BioCentury | Mar 24, 2014
Company News

Veracyte management update

...Julie Brooks as EVP, general counsel and secretary, formerly EVP, general counsel and secretary at Conceptus Inc....
BioCentury | Jun 17, 2013
Company News

Conceptus, Bayer deal

...Bayer completed its acquisition of Conceptus for $31 per share, or about $1.1 billion (see BioCentury...
...for $31 per share, or about $1.1 billion (see BioCentury, May 6 & May 13). Conceptus Inc....
BioCentury | May 13, 2013
Company News

Conceptus, Bayer deal

...began its tender offer to acquire Conceptus for $31 per share, which Bayer says values Conceptus...
...about $1.1 billion. The offer expires at midnight on June 5 (see BioCentury, May 6). Conceptus Inc....
BioCentury | May 6, 2013
Company News

Conceptus, Bayer deal

...Bayer says values Conceptus at about $1.1 billion. The price is a 20% premium to Conceptus'...
...of $25.90 on April 26, the last trading day prior to the announcement. Bayer gains Conceptus'...
...flexible inserts into the fallopian tubes. In 2012, Conceptus reported $141 million in net sales. Conceptus Inc....
BioCentury | Oct 12, 2009
Company News

American Medical Systems Holdings, Conceptus deal

...Women's health company Conceptus acquired from American Medical full rights to the Essure birth control system...
...purchase of all patents and IP associated with Ovion Inc. for $23.6 million in cash. Conceptus...
...tubes. American Medical acquired Ovion in 2005. American Medical Systems Holdings Inc. (NASDAQ:AMMD), Minnetonka, Minn. Conceptus Inc....
BioCentury | Feb 16, 2004
Company News

Caliper board of directors update

...Sciences Inc. (CALP), Hopkinton, Mass. Business: Microarrays Appointed: Kathryn Tunstall, former president and CEO of Conceptus Inc....
BioCentury | Feb 9, 2004
Company News

Caliper board of directors update

...Sciences Inc. (CALP), Hopkinton, Mass. Business: Microfluidics Appointed: Kathryn Tunstall, former president and CEO of Conceptus Inc....
BioCentury | Mar 8, 1999
Strategy

Spinner on the block

...from the sale of Target shares in the open market. Target spawned its own company, Conceptus Inc....
BioCentury | Jan 18, 1993
Strategy

What's driving spate of spin-offs

...one program," he said. Another CGEN offspring, Target Therapeutics Inc., just spawned its own company, Conceptus...
Items per page:
1 - 10 of 10